Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.
Clinical trial NCT00216242 · UNKNOWN
Trial details
- NCT number
- NCT00216242
- Sponsor
- ID Biomedical Corporation, Quebec
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 7400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.